Post-Marketing Clinical Study of REQUIP (Ropinirole Hydrochloride) Tablets in Patients With Parkinson's Disease- Evaluation of Long-Term Efficacy and Safety -
Phase of Trial: Phase IV
Latest Information Update: 27 May 2016
At a glance
- Drugs Levodopa; Ropinirole
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 31 Aug 2018 Biomarkers information updated
- 11 Jun 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 11 Jun 2010 Actual patient number (123) added as reported by ClinicalTrials.gov.